Plain-English translation of NCT03716089 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying laparoscopic surgery—a minimally invasive surgical technique using small incisions and a camera—to remove gastrointestinal stromal tumors (GISTs) from the stomach. Researchers want to understand whether the location of the tumor affects how well the surgery works and how many complications patients experience, comparing tumors in easier-to-reach spots with those in harder-to-reach areas of the stomach.
GIST tumors can occur in different locations within the stomach, and doctors aren't certain whether the tumor's location makes minimally invasive surgery more difficult or risky. This trial will help surgeons understand whether location matters for patient outcomes and safety.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive laparoscopic surgery to remove your stomach tumor—a minimally invasive procedure using small incisions and a camera rather than one large cut. After surgery, you'll be followed for three years to track whether your cancer stays gone and to monitor for any complications, with regular check-ups and imaging tests to assess your progress.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
China
Sponsor
Fujian Medical University
Enrollment target
~250 participants
Started
October 2018
Primary completion
April 2027
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in April 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.